AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US FDA has granted Breakthrough Therapy Designation...
Read more
Neovasc Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of...
Read more
CStone Pharmaceuticals announced that the National Medical Products Administration recently approved the clinical trial application (CTA) to start a Phase...
Read more
Amgen announced that the National Medical Products Administration (NMPA) has approved a new indication for Repatha as the first PCSK9...
Read more
Sanofi has received approval from the US FDA for 0.5ml Fluzone Quadrivalent vaccine to treat influenza in children aged between...
Read more
Clinical-stage company ImmusanT’s therapeutic vaccine candidate Nexvax2 has been granted fast track designation by the US FDA. ImmusanT uses its...
Read more
Gilead Sciences announced that the National Medical Products Administration (NMPA) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) in China...
Read more
Roche announced that the US FDA approved Tecentriq in combination with Avastin, paclitaxel and carboplatin (chemotherapy), for the initial (first-line)...
Read more
Shire plc the leading global biotechnology company focused on rare diseases, announced that the European Commission (EC) has granted Marketing...
Read more
Merck, known as MSD outside the United States and Canada, announced that the EC has approved DELSTRIGO™ and PIFELTRO™ for...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
